OCGN Competitors & Alternatives
Compare Ocugen Inc with similar stocks in the same industry
Biotechnology
OCGN
Main Stock$1.39
Tradestie Score
58
Market Cap
$524.67M
Revenue Growth
0.0%
Analyst Upside
+722.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$36.55
|
$505.12M | 1.8 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$9.97
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$95.14
|
$492.21M | - | 51 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.15
|
$474.20M | 26.7 | 58 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.08
|
$468.01M | - | 62 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$20.85
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$9.25
|
$457.09M | - | 58 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.76
|
$454.29M | - | 59 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$20.00
|
$448.32M | - | 63 | Compare |
More OCGN Analysis
Data updated: Jun 25, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry